Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rowan Miller
Pathological Chemotherapy Response Score Is Prognostic in Tubo-Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis of Individual Patient Data
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Diagnosis and Management of Breast Cancer in Men
Trends in Urology & Men's Health
Related publications
External Validation of Chemotherapy Response Score System for Histopathological Assessment of Tumor Regression After Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
Journal of Gynecologic Oncology
Medicine
Gynecology
Oncology
Obstetrics
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Serous Tubal Intraepithelial Carcinomas Associated With High-Grade Serous Ovarian Carcinomas: A Systematic Review
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
Prognostic Value of Abnormally Expressed lncRNAs in Ovarian Carcinoma: A Systematic Review and Meta-Analysis
Oncotarget
Oncology
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma
Modern Pathology
Forensic Medicine
Pathology
Prognostic Significance of Differential Expression of Angiogenic Genes in Women With High-Grade Serous Ovarian Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Diffusion Kurtosis MRI as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy in High Grade Serous Ovarian Cancer
Scientific Reports
Multidisciplinary
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
PLoS ONE
Multidisciplinary
